Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 26 peer-reviewed journal articles Updated
Nephrology

Understanding Your Diagnosis: Inherited Kidney Disease

At a Glance

Autosomal dominant progressive nephropathy with hypertension describes inherited kidney disease that can gradually reduce kidney function and raise blood pressure, but it is a broad label, not a single disorder. Genetic testing, imaging, and family history can clarify the diagnosis and family risk.

Being told you have autosomal dominant progressive nephropathy with hypertension can feel overwhelming. It is a complex phrase that sounds final, but in modern medicine, it is often used as a descriptive clinical label rather than a specific disease name [1][2]. This label tells your care team three important things: the condition runs in your family, it causes a slow decline in kidney function, and it is linked to high blood pressure.

While this description provides a starting point, the modern standard of care is to move toward a precise genetic diagnosis, when possible [3][4]. Identifying the specific gene involved can help your doctors predict how the disease might progress and what it means for your family members [5][6].

Deciphering the Diagnosis

To understand your situation, it helps to break down the medical terms into their core meanings:

  • Autosomal Dominant: This describes how the condition is passed down through families. “Autosomal” means the gene is not on a sex chromosome, so it affects men and women equally. “Dominant” means that only one parent needs to have the gene variant for it to be passed to a child. If a parent is known to carry a heterozygous pathogenic variant, each child typically has a 50% chance of inheriting the condition [7][8]. However, family history is sometimes absent because of a de novo variant (a new, spontaneous mutation), unrecognized disease, or reduced penetrance.
  • Progressive Nephropathy: Nephropathy simply means kidney disease. Progressive means that the kidneys’ ability to filter waste from your blood (often measured by eGFR, or estimated glomerular filtration rate) may slowly decline over many years or decades [9][10].
  • Hypertension: This is the medical term for high blood pressure. In this diagnosis, hypertension is not just a side effect; it is often a central part of the disease process [11][12].

Why Hypertension Matters

In many inherited kidney diseases, high blood pressure and kidney decline form a self-reinforcing cycle. As kidney function drops, the body may struggle to manage salt and fluids, which raises blood pressure [11]. Conversely, high blood pressure puts physical stress on the small blood vessels in the kidneys, which can accelerate the damage [11].

In certain conditions, like Autosomal Dominant Polycystic Kidney Disease (ADPKD), hypertension often appears even before there is any measurable change in kidney function [13][14]. This happens because growing cysts can pinch internal blood vessels, tricking the kidneys into releasing hormones that skyrocket blood pressure [12][15]. Managing your blood pressure is one of the most effective ways to slow the “progressive” part of your diagnosis and protect your heart [16][13].

What This Label Does and Does Not Tell You

Because “autosomal dominant progressive nephropathy” is a broad description, it can actually represent several different genetic conditions. Your doctor will look at your family history, imaging (like an ultrasound or CT scan), and blood work to narrow it down:

Potential Specific Diagnosis Key Features
ADPKD Large kidneys filled with many fluid-filled cysts; may also involve liver cysts [17][18].
ADTKD Normal-sized or small kidneys; often “bland” urine (no blood or high protein); may be linked to early-life gout [9][19].
HNF1B-related Disease May include structural abnormalities of the kidneys and a specific type of early-onset diabetes [20][21].
Alport Syndrome Can involve kidney decline and hypertension, but often also affects hearing or vision (can be autosomal dominant, recessive, or X-linked) [5].

What This Means for Your Family

Because the inheritance is suspected to be autosomal dominant, your diagnosis is a family matter. If you have a confirmed genetic variant, your siblings and children may also be at risk [22].

Modern guidelines recommend “thinking genetic” whenever kidney disease appears in multiple generations or at a young age [3]. Genetic testing is a valuable tool for confirming which condition you have [8][23]. This information is vital for relatives who may want to be screened early or for those considering being a living kidney donor, as it ensures they do not unknowingly have the same condition [22][24]. Identifying the specific gene can also open the door to family planning options, such as testing embryos before pregnancy, and is crucial for preconception counseling, as many CKD medications must be changed before pregnancy [25][26].

Common questions in this guide

What does autosomal dominant progressive nephropathy with hypertension mean?
It is a broad clinical description rather than one specific disease. It suggests an inherited kidney condition that may gradually reduce kidney filtering ability and is linked to high blood pressure. Genetic testing, kidney imaging, and family history can help identify the underlying condition.
If I have an autosomal dominant kidney condition, what is my child’s risk?
If one parent has a confirmed disease-causing variant in one copy of a gene, each child typically has a 50% chance of inheriting it. The actual risk can vary when a variant has reduced penetrance, or when the genetic change occurred newly in the affected person. A genetics professional can explain the risk in your family.
How do doctors identify the specific inherited kidney disease?
Doctors may combine your family history with kidney imaging, such as an ultrasound or CT scan, blood and urine findings, and genetic testing. Enlarged kidneys with many cysts, small or normal-sized kidneys, early gout, diabetes, or hearing and vision changes can provide clues to different conditions. Genetic testing may confirm the specific gene involved.
Why is high blood pressure important when kidney function is declining?
Kidney disease can make it harder for the body to control salt and fluid, which can raise blood pressure. High blood pressure can then place additional stress on kidney blood vessels and speed kidney damage. Working with your healthcare team to control blood pressure may help protect kidney and heart health.
Which inherited kidney diseases could this description refer to?
The label may describe conditions such as autosomal dominant polycystic kidney disease, autosomal dominant tubulointerstitial kidney disease, HNF1B-related disease, or Alport syndrome. Enlarged cystic kidneys can suggest the first condition, while small or normal-sized kidneys with little blood or protein in the urine and early gout can suggest the second. Early diabetes or kidney structure changes may point toward HNF1B-related disease, and hearing or vision problems can be clues to Alport syndrome.
Should my siblings or children consider genetic testing?
If a disease-causing genetic variant is confirmed, siblings and children may have an increased chance of carrying it. Genetic counseling can help relatives decide whether testing or early kidney and blood pressure screening is appropriate. The information can also be important when a relative is considering becoming a living kidney donor.
How can a genetic diagnosis help with pregnancy planning or kidney donation?
Identifying the specific gene can support counseling before pregnancy and may provide options such as testing embryos before pregnancy. Relatives considering living kidney donation should be evaluated so they do not unknowingly carry the same condition. Medication plans may also need review before pregnancy.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Has my condition been linked to a specific gene yet, such as PKD1, PKD2, or UMOD?
  2. 2.Does my kidney imaging show enlarged kidneys with cysts, or are they normal-sized or small?
  3. 3.Is my hypertension a result of my kidney disease, or is it also making my kidney function decline faster?
  4. 4.Should we pursue genetic testing for me to help my siblings or children understand their risks?
  5. 5.Are there specific blood pressure targets I should aim for to protect my kidneys?
  6. 6.Do I have any 'extra-renal' features, such as liver cysts or a history of gout, that point toward a specific diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (26)
  1. 1

    Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

    Eckardt KU, Alper SL, Antignac C, et al.

    Kidney international 2015; (88(4)):676-83 doi:10.1038/ki.2015.28.

    PMID: 25738250
  2. 2

    Autosomal dominant tubulointerstitial kidney disease.

    Devuyst O, Olinger E, Weber S, et al.

    Nature reviews. Disease primers 2019; (5(1)):60 doi:10.1038/s41572-019-0109-9.

    PMID: 31488840
  3. 3

    Genetic kidney disease in adults-the pathologists' perspective.

    Paterson AL, Chan MMY, Roufosse C

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2026; (41(8)):1421-1428 doi:10.1093/ndt/gfag047.

    PMID: 41848274
  4. 4

    Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

    Kidney international 2022; (101(6)):1126-1141 doi:10.1016/j.kint.2022.03.019.

    PMID: 35460632
  5. 5

    Genomics in the kidney clinic.

    Doctor GT, Gale DP, Chan MM

    Clinical medicine (London, England) 2023; (23(3)):246-249 doi:10.7861/clinmed.2023-RM2.

    PMID: 37236798
  6. 6

    Genetic Counseling in Kidney Disease: A Perspective.

    Stein Q, Westemeyer M, Darwish T, et al.

    Kidney medicine 2023; (5(7)):100668 doi:10.1016/j.xkme.2023.100668.

    PMID: 37334143
  7. 7

    Autosomal dominant tubulointerstitial kidney disease: A review.

    Živná M, Kidd KO, Barešová V, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2022; (190(3)):309-324 doi:10.1002/ajmg.c.32008.

    PMID: 36250282
  8. 8

    Autosomal Dominant Tubulointerstitial Kidney Disease.

    Bleyer AJ, Kidd K, Živná M, Kmoch S

    Advances in chronic kidney disease 2017; (24(2)):86-93 doi:10.1053/j.ackd.2016.11.012.

    PMID: 28284384
  9. 9

    Autosomal Dominant Tubulointerstitial Kidney Disease: A Review.

    Bleyer AJ, Kidd KO, Živná M, Kmoch S

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2025; (86(5)):677-689 doi:10.1053/j.ajkd.2025.05.015.

    PMID: 40835155
  10. 10

    Autosomal Dominant Tubulointerstitial Kidney Disease Clinical Trial Simulator: Case Reports of Model-Informed Drug Development.

    Ramesh SS, Rogge M, Kim J, et al.

    CPT: pharmacometrics & systems pharmacology 2026; (15(5)):e70258 doi:10.1002/psp4.70258.

    PMID: 42062819
  11. 11

    Hypertension in Cardiovascular and Kidney Disease: Recent Trends - Treating Two Diseases as One.

    De Pascalis A, Tomassetti A, Vetrano D, et al.

    Cardiorenal medicine 2024; (14(1)):581-587 doi:10.1159/000541876.

    PMID: 39374593
  12. 12

    Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.

    Park HC, Kang AY, Jang JY, et al.

    BMC nephrology 2015; (16()):86 doi:10.1186/s12882-015-0075-8.

    PMID: 26092580
  13. 13

    The wind of change in the management of autosomal dominant polycystic kidney disease in childhood.

    Gimpel C, Bergmann C, Mekahli D

    Pediatric nephrology (Berlin, Germany) 2022; (37(3)):473-487 doi:10.1007/s00467-021-04974-4.

    PMID: 33677691
  14. 14

    Increasing prevalence of hypertension during long-term follow-up in children with autosomal dominant polycystic kidney disease.

    Seeman T, Jansky P, Filip F, et al.

    Pediatric nephrology (Berlin, Germany) 2021; (36(11)):3717-3723 doi:10.1007/s00467-021-05104-w.

    PMID: 34008126
  15. 15

    Urinary renin-angiotensin markers in polycystic kidney disease.

    Salih M, Bovée DM, Roksnoer LCW, et al.

    American journal of physiology. Renal physiology 2017; (313(4)):F874-F881 doi:10.1152/ajprenal.00209.2017.

    PMID: 28747358
  16. 16

    New insights in the pathophysiology and treatment of hypertension in autosomal dominant polycystic kidney disease.

    Dumont A, Bellien J, Van Wynsberghe M, et al.

    Kidney international 2025; (108(4)):592-608 doi:10.1016/j.kint.2025.05.036.

    PMID: 40712885
  17. 17

    Autosomal dominant polycystic kidney disease: Current perspectives in 2026.

    Pichette M, Park M, Cornec-Le Gall E

    La Revue de medecine interne 2026; (47(9)):490-499 doi:10.1016/j.revmed.2026.05.003.

    PMID: 42315404
  18. 18

    Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes.

    Yang H, Sieben CJ, Schauer RS, Harris PC

    Advances in kidney disease and health 2023; (30(5)):397-406 doi:10.1053/j.akdh.2023.04.004.

    PMID: 38097330
  19. 19

    Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.

    Gonçalves F, Lisboa-Gonçalves P, Quental R, et al.

    Nefrologia 2024; (44(4)):576-581 doi:10.1016/j.nefroe.2024.08.002.

    PMID: 39216982
  20. 20

    Two sides of the same coin: a complex presentation of autosomal dominant tubulointerstitial kidney diseases: a literature review and case reports.

    Fistrek Prlic M, Huljev Frkovic S, Beck B, et al.

    Frontiers in pediatrics 2023; (11()):1283325 doi:10.3389/fped.2023.1283325.

    PMID: 38027261
  21. 21

    Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.

    van der Made CI, Hoorn EJ, de la Faille R, et al.

    American journal of nephrology 2015; (42(1)):85-90 doi:10.1159/000439286.

    PMID: 26340261
  22. 22

    Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation.

    Thomas CP, Gupta S, Freese ME, et al.

    Transplant international : official journal of the European Society for Organ Transplantation 2021; (34(12)):2696-2705 doi:10.1111/tri.14133.

    PMID: 34632641
  23. 23

    Autosomal Dominant Tubulointerstitial Kidney Disease: Approach to Diagnosis.

    Connaughton DM, Arnaldi M, Kidd KO, Bleyer AJ

    Advances in kidney disease and health 2026; (33(1)):37-47 doi:10.1053/j.akdh.2026.04.003.

    PMID: 42175989
  24. 24

    Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices.

    Thomas CP, Daloul R, Lentine KL, et al.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2023; (23(5)):597-607 doi:10.1016/j.ajt.2023.02.020.

    PMID: 36868514
  25. 25

    Atrial septal defects, supravalvular aortic stenosis and syndromes predisposing to aneurysm of large vessels.

    Baglivo M, Dassati S, Krasi G, et al.

    Acta bio-medica : Atenei Parmensis 2019; (90(10-S)):53-57 doi:10.23750/abm.v90i10-S.8760.

    PMID: 31577255
  26. 26

    Application of single-sperm sequencing in a male with Marfan syndrome: a case report and a literature review.

    Li C, Zhou F, Tan J, et al.

    Journal of genetics 2021; (100()).

    PMID: 34057151

This page is for informational purposes only and does not constitute medical advice. Your nephrologist and genetics team should interpret your test results and recommend care for your specific situation.

Get notified when new evidence is published on Autosomal dominant progressive nephropathy with hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.